University of Illinois at Chicago
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Illinois at Chicago sits in the top decile of US sponsors by registered trial count (#83 of 15,742 sponsors by registered trial count).
University of Illinois at Chicago: 430 sponsored US clinical trials, 115 recruiting.
University of Illinois at Chicago sponsors 430 registered US clinical trials on ClinicalTrials.gov, 115 of them currently recruiting, and 236 completed. 30 of these trials are in Phase 3-4 (later-stage) and 80 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Multiple Sclerosis, with 10 trials.
Top-decile sponsor footprint
University of Illinois at Chicago ranks in the top decile of sponsors by registered trial count (#83 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
236 of 271 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
430 total, page 6 of 9
SUpPress SSI - Single Use Negative Pressure Wound Therapy (NPWT) to Reduce Surgical Site Infections
NCT03816293
TIPS Plus Transvenous Obliteration for Gastric Varices
NCT04044248
Licorice Botanical Dietary Supplements - Metabolism and Safety in Women
NCT03948243
Effect of Age and Fitness on Vascular Function and Oxidative Stress During Acute Inflammation
NCT03889158
Promoting Activity After COPD Exacerbations, Aim 2
NCT03793192
Engaging Self-regulation Targets to Improve Mood and Weight and Understand Mechanism in Depressed and Obese Adults
NCT03841682
Targeting of UnControlled Hypertension in Emergency Department
NCT03749499
Sleep Duration in Women With Previous Gestational Diabetes
NCT03638102
Time Restricted Feeding (4-hour Versus 6-hour) for Weight Loss in Obese Adults
NCT03867773
Enhancing Well-Being Through Exercise During Old Age
NCT04536727
Patient-centered Mobile Health Intervention to Improve Self-care in Patients With Chronic Heart Failure
NCT03642275
A Cognitive Behavioral Therapy (CBT) Intervention to Reduce Fear of Hypoglycemia in Type 1 Diabetes
NCT03549104
A Sleep Intervention in Type 1 Diabetes
NCT03617770
Gingival Crevicular Fluid Characterization During Orthodontic Treatment
NCT04226469
Treating Inflammation in Polycystic Ovary Syndrome to Ameliorate Ovarian Dysfunction
NCT03229408
VR-CogMoBal Training for Reducing Falls Among Older Adults With Mild Cognitive Impairment
NCT03765398
A Randomized Placebo Controlled Pilot Study of Probiotic Supplementation in At-risk Pregnant Women
NCT03646487
Effectiveness of Alternative Therapy for Improving Cognition, Balance, and Physical Activity
NCT04160299
Reducing Barriers and Sustaining Utilization of a Cervical Cancer Screening Program in Rural Senegal
NCT03540069
Development of a Clinically-relevant Test for Assessment of Cerebral Vascular Function
NCT04336852
Neuro Biomarkers of Smoking Behavior
NCT03811951
Integrating Contextual Factors Into Clinical Decision Support
NCT03244033
Diet Modulation of Bacterial Sulfur and Bile Acid Metabolism and Colon Cancer Risk
NCT03550885
Unique Effects of Perimenstrual Estradiol or Progesterone Supplementation on Perimenstrual Suicidality
NCT03498313
Alternate Day Fasting Combined With a High Protein Background Diet
NCT03528317
Additional Signals for Exercise, Stress and Sleep and Prediction of Glucose Levels for AP Systems
NCT04725799
Blood Flow in Individuals With Down Syndrome
NCT03590665
Acupuncture for Vulvodynia: A Pre-pilot Study
NCT02704234
Effect of Acupuncture on Patient Vulvodynia Outcomes
NCT03364127
Randomized Controlled Trial of Big Brothers Big Sisters Mentoring for Prevention of Crime and Delinquency
NCT03495635
Use of a Reproductive Life Planning Tool at the Pediatric Well-Baby Visit With Postpartum Women
NCT03448289
Pilot Evaluation of an Interactive Health Game
NCT03444129
Coordinated Oral Health Promotion (CO-OP) Chicago
NCT03397589
Improving White Matter Integrity With Thyroid Hormone
NCT04098991
physicAl aCtiviTy In minOrity womeN With Asthma Intervention
NCT03265665
Red Clover Botanical Dietary Supplements - Metabolism and Safety in Women
NCT03205787
Testing Self-Directed Care in Florida
NCT05649449
Promoting Seniors' Health With Home Care Aides
NCT03301116
Exercise Training and Cognitive Function in Kidney Disease
NCT03197038
Transdiagnostic Brain-Behavior Profiling to Enhance Cognitive Behavioral Therapy Response
NCT03175068
Converting Elderly Kidney Transplant Recipients From Tacrolimus to Envarsus to Limit Neurological AE and Improve QOL
NCT03263052
Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study)
NCT03137303
Alternating Pressure Overlay on Weight Bearing Tissue Tolerance in People With Spinal Cord Injury
NCT03317288
Primary Care and Parenting
NCT03146572
mHealth for Diabetes Adherence Support
NCT02990299
Randomization of Early Diabetes Screening Among Obese Pregnant Women.
NCT03116009
Feeding the Critically Ill During Phases of Altered Redox Status
NCT03085615
PHAT Life: Peer Versus Adult-Led HIV Prevention for Juvenile Offenders
NCT03555279
Empowering Latinas to Obtain Breast Cancer Screenings
NCT02964234
Targeting Anhedonia in Cocaine Use Disorder
NCT02773212
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 37 |
| Phase 2 | 43 |
| Phase 3 | 11 |
| Phase 4 | 19 |
Therapeutic Areas
What is open in the University of Illinois at Chicago pipeline
115 recruiting of 430 indexed (27% open); 236 completed (55%).
Phase mix: 30 late (III/IV) vs 80 early (I/II) (early-phase heavy).
Top condition: Multiple Sclerosis (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Illinois at Chicago: open-pipeline peers nationwide
Peers matched on 430 registered trials and 27% open enrollment, not the therapeutic-area sidebar.
University of Illinois at Chicago sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 430 trials (± recruiting share)
- Vanderbilt University · 430 trials · 3% recruiting
- Children's Hospital of Philadelphia · 431 trials · 18% recruiting
- Novo Nordisk A/S · 431 trials · 8% recruiting
- Dartmouth-Hitchcock Medical Center · 427 trials · 12% recruiting
Sponsors near 27% open enrollment (± trial volume)
- Coherus Oncology · 27% recruiting · 15 trials
- NewAmsterdam Pharma · 27% recruiting · 15 trials
- Portland VA Medical Center · 27% recruiting · 15 trials
- White River Junction Veterans Affairs Medical Center · 27% recruiting · 15 trials
Related
What to do with this University of Illinois at Chicago page
430 registered trials is a research-attention snapshot, not an endorsement of University of Illinois at Chicago or any single study.
- 115 of University of Illinois at Chicago's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Multiple Sclerosis is the condition University of Illinois at Chicago studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Multiple Sclerosis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Illinois at Chicago pipeline card: 430 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.